Jazz Pharmaceuticals Revenue 2007-2019 | JAZZ

Jazz Pharmaceuticals annual/quarterly revenue history and growth rate from 2007 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Jazz Pharmaceuticals revenue for the quarter ending September 30, 2019 was $0.538B, a 14.56% increase year-over-year.
  • Jazz Pharmaceuticals revenue for the twelve months ending September 30, 2019 was $2.056B, a 11.11% increase year-over-year.
  • Jazz Pharmaceuticals annual revenue for 2018 was $1.891B, a 16.82% increase from 2017.
  • Jazz Pharmaceuticals annual revenue for 2017 was $1.619B, a 8.79% increase from 2016.
  • Jazz Pharmaceuticals annual revenue for 2016 was $1.488B, a 12.32% increase from 2015.
Jazz Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $1,891
2017 $1,619
2016 $1,488
2015 $1,325
2014 $1,173
2013 $872
2012 $586
2011 $272
2010 $174
2009 $128
2008 $68
2007 $65
2006 $45
2005 $21
Jazz Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q3 2019 $538
Q2 2019 $534
Q1 2019 $508
Q4 2018 $476
Q3 2018 $469
Q2 2018 $500
Q1 2018 $445
Q4 2017 $436
Q3 2017 $412
Q2 2017 $394
Q1 2017 $376
Q4 2016 $397
Q3 2016 $374
Q2 2016 $381
Q1 2016 $336
Q4 2015 $341
Q3 2015 $341
Q2 2015 $334
Q1 2015 $309
Q4 2014 $328
Q3 2014 $307
Q2 2014 $291
Q1 2014 $247
Q4 2013 $236
Q3 2013 $232
Q2 2013 $208
Q1 2013 $196
Q4 2012 $184
Q3 2012 $176
Q2 2012 $124
Q1 2012 $103
Q4 2011 $84
Q3 2011 $73
Q2 2011 $65
Q1 2011 $51
Q4 2010 $53
Q3 2010 $45
Q2 2010 $40
Q1 2010 $35
Q4 2009 $38
Q3 2009 $31
Q2 2009 $37
Q1 2009 $22
Q4 2008 $20
Q3 2008 $18
Q2 2008 $16
Q1 2008 $15
Q4 2007 $15
Q3 2007 $21
Q2 2007 $14
Q1 2007 $14
Q4 2006
Q3 2006 $11
Q2 2006 $11
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $8.245B $1.891B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $64.924B 38.83
Takeda Pharmaceutical (TAK) Japan $61.813B 9.77
Astellas Pharma (ALPMY) Japan $32.875B 16.42
Eisai (ESALY) Japan $21.999B 42.41
Merck (MKGAF) Germany $16.989B 23.18
Grifols, S.A (GRFS) Spain $15.869B 20.79
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Neurocrine Biosciences (NBIX) United States $9.133B 431.17
Catalent (CTLT) United States $9.010B 36.65
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Ionis Pharmaceuticals (IONS) United States $8.358B 16.93
STADA ARZNEIMI (STDAF) Germany $5.972B 0.00
IPSEN SA ADR (IPSEY) France $5.862B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.282B 16.07
Arrowhead Pharmaceuticals (ARWR) United States $4.270B 64.65
Evotec AG (EVTCY) Germany $4.074B 65.85
United Therapeutics (UTHR) United States $3.920B 0.00
Nektar Therapeutics (NKTR) United States $3.717B 0.00
FibroGen (FGEN) United States $3.647B 107.18
Sage Therapeutics (SAGE) United States $3.525B 0.00
PTC Therapeutics (PTCT) United States $3.200B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.198B 11.77
ChemoCentryx (CCXI) United States $2.396B 0.00
Zogenix (ZGNX) United States $2.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.119B 0.00
Heron Therapeutics (HRTX) United States $2.035B 0.00
Tilray (TLRY) Canada $1.985B 0.00
Xencor (XNCR) United States $1.947B 59.19
Ironwood Pharmaceuticals (IRWD) United States $1.940B 61.85
Pacira Pharmaceuticals (PCRX) United States $1.828B 54.09
USANA Health Sciences (USNA) United States $1.608B 17.16
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.492B 18.13
Theravance Biopharma (TBPH) Cayman Islands $1.487B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.415B 9.65
Endo (ENDP) Ireland $1.343B 2.47
Enanta Pharmaceuticals (ENTA) United States $1.087B 24.71
Portola Pharmaceuticals (PTLA) United States $1.062B 0.00
Karyopharm Therapeutics (KPTI) United States $1.036B 0.00
Dermira (DERM) United States $1.020B 0.00
Aerie Pharmaceuticals (AERI) United States $0.996B 0.00
Akebia Therapeutics (AKBA) United States $0.943B 0.00
Radius Health (RDUS) United States $0.870B 0.00
Collegium Pharmaceutical (COLL) United States $0.702B 0.00
TherapeuticsMD (TXMD) United States $0.673B 0.00
Flexion Therapeutics (FLXN) United States $0.671B 0.00
ImmunoGen (IMGN) United States $0.659B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.547B 0.00
Molecular Templates (MTEM) United States $0.501B 0.00
Translate Bio (TBIO) United States $0.483B 0.00
Ardelyx (ARDX) United States $0.467B 0.00
Organogenesis Holdings (ORGO) United States $0.459B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.437B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.434B 0.00
Innate Pharma SA (IPHYF) France $0.432B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.422B 0.00
Siga Technologies (SIGA) United States $0.418B 9.56
BioCryst Pharmaceuticals (BCRX) United States $0.417B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.415B 17.91
Catalyst Pharmaceuticals (CPRX) United States $0.410B 49.75
DURECT (DRRX) United States $0.385B 0.00
OptiNose (OPTN) United States $0.371B 0.00
Calithera Biosciences (CALA) United States $0.363B 0.00
Recro Pharma (REPH) United States $0.361B 0.00
Lannett Co Inc (LCI) United States $0.361B 4.20
Harpoon Therapeutics (HARP) United States $0.360B 0.00
Rafael Holdings (RFL) United States $0.345B 0.00
Indivior (INVVY) United States $0.335B 1.21
KalVista Pharmaceuticals (KALV) United States $0.305B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.259B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.258B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.256B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.239B 0.00
MEI Pharma (MEIP) United States $0.237B 0.00
Ocular Therapeutix (OCUL) United States $0.217B 0.00
IMV INC (IMV) Canada $0.212B 0.00
Jounce Therapeutics (JNCE) United States $0.210B 2.80
La Jolla Pharmaceutical (LJPC) United States $0.206B 0.00
Nature's Sunshine Products (NATR) United States $0.193B 33.23
Taiwan Liposome (TLC) Taiwan $0.176B 0.00
Xeris Pharmaceuticals (XERS) United States $0.155B 0.00
CannTrust Holdings (CTST) Canada $0.150B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.139B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.139B 0.00
Redhill Biopharma (RDHL) Israel $0.131B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.121B 0.00
CV Sciences (CVSI) United States $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Otonomy (OTIC) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.095B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.094B 0.00
PolarityTE (PTE) United States $0.091B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.090B 0.00
Neos Therapeutics (NEOS) United States $0.088B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Infinity Pharmaceuticals (INFI) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 22.73
CTI BioPharma (CTIC) United States $0.074B 0.00
RENEURON GP (RNUGF) United Kingdom $0.074B 0.00
AgeX Therapeutics (AGE) United States $0.067B 0.00
Aclaris Therapeutics (ACRS) United States $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.062B 15.39
Nivalis Therapeutics (ALPN) United States $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
IsoRay (ISR) United States $0.056B 0.00
Onconova Therapeutics (ONTX) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Jaguar Animal Health (JAGX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Biomerica (BMRA) United States $0.030B 0.00
PharmAthene (ALT) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.026B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
VAXART, INC (VXRT) United States $0.024B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
Novan (NOVN) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Shineco (TYHT) China $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.012B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
Heat Biologics (HTBX) United States $0.010B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00